Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Methods Mol Biol ; 2381: 97-112, 2021.
Article in English | MEDLINE | ID: mdl-34590272

ABSTRACT

Genetic perturbation assays have been crucial to the discovery of molecular pathways that drive diverse biological processes. RNA interference (RNAi)-mediated depletion of gene products represents a powerful means of elucidating gene function, as it allows one to systematically probe the phenotypic effects resulting from the functional loss of specific targets. The relative ease of use of RNAi technologies in cultured cells has allowed the design and implementation of genome-wide investigations to systematically reveal gene function. In this chapter, we describe methods for high-throughput RNAi-mediated loss-of-function studies in cultured cells of Drosophila melanogaster. First, we describe the in vitro synthesis of double stranded RNAs (dsRNAs) from a genome-wide Drosophila RNAi library. Next, we outline the procedures used to carry out high-throughput RNAi screens using a cell bathing approach and high-content screening microscopy, illustrating how these experiments can be utilized to study specific cellular contexts, such as cellular stress. Finally, we illustrate some approaches commonly employed to validate the depletion of identified gene candidates.


Subject(s)
Drosophila melanogaster , Animals , Cells, Cultured , Drosophila melanogaster/genetics , RNA Interference , RNA, Double-Stranded/genetics
2.
Genome Res ; 29(11): 1816-1825, 2019 11.
Article in English | MEDLINE | ID: mdl-31519740

ABSTRACT

RNA sequencing (RNA-seq) is a sensitive and accurate method for quantifying gene expression. Small samples or those whose RNA is degraded, such as formalin-fixed paraffin-embedded (FFPE) tissue, remain challenging to study with nonspecialized RNA-seq protocols. Here, we present a new method, Smart-3SEQ, that accurately quantifies transcript abundance even with small amounts of total RNA and effectively characterizes small samples extracted by laser-capture microdissection (LCM) from FFPE tissue. We also obtain distinct biological profiles from FFPE single cells, which have been impossible to study with previous RNA-seq protocols, and we use these data to identify possible new macrophage phenotypes associated with the tumor microenvironment. We propose Smart-3SEQ as a highly cost-effective method to enable large gene expression profiling experiments unconstrained by sample size and tissue availability. In particular, Smart-3SEQ's compatibility with FFPE tissue unlocks an enormous number of archived clinical samples; combined with LCM it allows unprecedented studies of small cell populations and single cells isolated by their in situ context.


Subject(s)
Gene Expression Profiling/methods , Laser Capture Microdissection/methods , Sequence Analysis, RNA/methods , Single-Cell Analysis/methods , Humans , Macrophages/metabolism , Reproducibility of Results , Tumor Microenvironment
3.
Neuron ; 103(5): 802-819.e11, 2019 09 04.
Article in English | MEDLINE | ID: mdl-31272829

ABSTRACT

Stress granules (SGs) form during cellular stress and are implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). To yield insights into the role of SGs in pathophysiology, we performed a high-content screen to identify small molecules that alter SG properties in proliferative cells and human iPSC-derived motor neurons (iPS-MNs). One major class of active molecules contained extended planar aromatic moieties, suggesting a potential to intercalate in nucleic acids. Accordingly, we show that several hit compounds can prevent the RNA-dependent recruitment of the ALS-associated RNA-binding proteins (RBPs) TDP-43, FUS, and HNRNPA2B1 into SGs. We further demonstrate that transient SG formation contributes to persistent accumulation of TDP-43 into cytoplasmic puncta and that our hit compounds can reduce this accumulation in iPS-MNs from ALS patients. We propose that compounds with planar moieties represent a promising starting point to develop small-molecule therapeutics for treating ALS/FTD.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Cytoplasmic Granules/drug effects , DNA-Binding Proteins/drug effects , Frontotemporal Dementia/metabolism , Motor Neurons/drug effects , Protein Aggregation, Pathological/metabolism , Small Molecule Libraries/pharmacology , Stress, Physiological/drug effects , Cell Line , Cytoplasmic Granules/metabolism , DNA Helicases/genetics , DNA-Binding Proteins/metabolism , HEK293 Cells , Heterogeneous-Nuclear Ribonucleoprotein Group A-B/metabolism , High-Throughput Screening Assays , Humans , Induced Pluripotent Stem Cells , Intrinsically Disordered Proteins , Motor Neurons/metabolism , Neural Stem Cells/drug effects , Neural Stem Cells/metabolism , Poly-ADP-Ribose Binding Proteins/genetics , RNA Helicases/genetics , RNA Recognition Motif Proteins/genetics , RNA-Binding Protein FUS/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...